Mary Felzkowski: Cole’s Act calls for Pharmacy Benefit Manager reform
A column from the Senate president
A column from the Senate president
Axial spondyloarthritis (axSpA) is a chronic inflammatory condition that significantly affects patients’ quality of life.1 Accurate assessment of disease activity is critical for both clinical…
The ACR Career Connection is a recruiting service for job seekers and employers in the field of rheumatology.
DESTIN, Fla. — Raising the rheumatology community’s “aspirations” for immune-mediated inflammatory disease treatment could lead to better patient outcomes, according to a speaker at the…
The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far…
Objectives Tapering of tumor necrosis factor inhibitor (TNFi) treatment in rheumatoid arthritis (RA) remission is debated. We assessed the effect of tapering TNFi to withdrawal…
Listen as coinvestigator and rheumatologist Dr. Andrea Rubbert-Roth reviews this Phase 3 trial of a JAKi in patients with giant cell arteritis. Dr. Rubbert-Roth discusses…
The FDA has approved the Janus kinase inhibitor upadacitinib for the treatment of giant cell arteritis in adults, the first such approval in the disease…
The Health Advocates A podcast that breaks down major health news of the week to help you make sense of it all.
lting disability in cLBP. This article aims to examine the associations of back function with FAB. Methods: This study presents data from a cohort study…
Biomarkers in blood and plasma can be used to predict rheumatoid arthritis-associated interstitial lung disease more accurately than clinical risk factors alone, suggesting potential new…